BiotechTube
Home/Pipeline/AC-203

AC-203

Epidermolysis Bullosa Simplex

Phase 3Active

Key Facts

Indication
Epidermolysis Bullosa Simplex
Phase
Phase 3
Status
Active
Company
TWi Biotechnology

About TWi Biotechnology

Taiwan biotech repurposing approved drugs for rare dermatologic and CNS indications.

View full company profile

Therapeutic Areas

DermatologyCNS DisordersRare DiseasesPsychiatryImmunology